Financial impact on care and reimbursement
The financial relationship between healthcare providers and insurance payers has grown more complex. This complexity stretches beyond medical billing departments. Across physician practices, medical groups, and integrated systems, challenges rise. Rising claim denials and prior authorization burdens create uncertainty and administrative obstacles.
Moreover, Denial burdens have shifted from an operational issue to a strategic concern. Claims remain a source of financial uncertainty for practices. These pressures affect profitability, productivity, clinical autonomy, and organizational sustainability. Additionally, payer policies evolve, widening the gap between care and reimbursement. Clinicians and administrators must harmonize workflows to reduce delays.
It was once seen as routine reimbursement work. It now influences resource allocation, policy decisions, and patient outcomes. Organizations seek sustainable models that balance care quality with cost control. Effective governance and transparent reporting help reduce fluctuations in revenue.
Recent industry findings reveal the scale of these challenges today. According to Experian Health’s 2025 State of Claims survey, 41% of providers reported claim denial rates of at least 10% overall. Furthermore, this compares with 30% in the organization’s 2022 survey.
Additionally, 68% said submitting clean claims has become more challenging than in the preceding year. These findings reflect the experiences of surveyed organizations rather than a national database. They illustrate growing difficulties providers face in securing timely, accurate reimbursement for services.
For physician practices, the implications are particularly consequential. Reimbursement delays create immediate pressure on operating cash flow, while repeated administrative interventions increase the cost of collecting revenue. More importantly, physicians are increasingly drawn into processes that compete with clinical responsibilities. These developments raise a critical question for healthcare leadership: To what extent are payer administrative requirements and reimbursement inefficiencies compromising the financial and operational capacity of organizations to deliver care?
The Financial Consequences Extend Beyond Denied Claims
Claim denials are frequently evaluated through operational indicators such as initial denial rates, appeal volumes, and recovery percentages. These measurements provide important information.
However, a denied claim represents more than an interruption in payment. It initiates additional administrative activity and requires allocating personnel. It also extends the period between service delivery and revenue realization. These effects can complicate cash flow management for physician organizations.
For physician practices, the cumulative effect of these activities can materially influence financial performance. Medical groups must continue meeting payroll obligations, maintaining facilities, supporting clinical operations, and investing in technology regardless of whether reimbursement is received according to anticipated timelines. As claims remain unresolved, revenue is effectively tied up in accounts receivable while the expenses associated with delivering services have already been incurred. This imbalance can become especially problematic for smaller practices operating with limited financial reserves or experiencing growing staffing and operating costs.
An additional concern is the distinction between recovering a denied payment and recovering its full economic value. A successfully appealed claim may ultimately produce the reimbursement originally expected, but the associated administrative costs remain. Billing specialists, coders, clinical staff, and physicians may have spent considerable time investigating payer requirements, compiling records, preparing appeals, or conducting peer-to-peer reviews. Even when the payer reverses its initial decision, the practice has absorbed additional costs to collect revenue for services already provided.
These expenses are often dispersed across departmental budgets, making the true cost of denials difficult to identify through conventional revenue cycle reporting. A practice may demonstrate relatively strong gross collection performance while experiencing declining operating efficiency because of repeated claim rework and increasingly complex payer requirements. Consequently, healthcare executives should consider denial performance within the broader context of administrative cost, net revenue realization, cash flow predictability, and operating margin.
The financial burden also extends to physician practice growth and investment decisions. Organizations experiencing persistent reimbursement delays may defer recruitment, reduce discretionary spending, postpone technology upgrades, or reconsider service expansion. In this respect, rising denials represent a potential constraint on organizational development rather than merely a temporary billing inconvenience. Understanding the economic consequences requires moving beyond denial percentages to evaluate the relationship between reimbursement outcomes, administrative resource consumption, and long-term financial sustainability.
Administrative Complexity Is Reshaping the Practice of Medicine
The financial consequences of increasing denials are substantial.
However, the effects on physicians and clinical operations are equally important.
Healthcare reimbursement processes increasingly require physician participation in activities that may have limited direct clinical value.
These activities include additional documentation, medical necessity justification, payer correspondence, peer-to-peer discussions, and appeals of adverse coverage determinations.
Activities like these can compete with patient appointments.
They also compete with clinical coordination, practice administration, and other activities central to the delivery of care.
Prior authorization illustrates how administrative requirements can influence physician workload before reimbursement is even considered. Unlike a claim denial, which generally follows the submission of a bill for services, a prior authorization denial involves a payer’s determination concerning coverage approval before a planned service or treatment. Although these processes occur at different stages of the healthcare revenue life cycle, both can generate substantial administrative obligations and contribute to financial and operational uncertainty.
Findings from the American Medical Association’s physician survey released in May 2026 demonstrate the extent of the perceived burden. Surveyed physicians reported completing an average of 40 prior authorization requests per physician each week, requiring approximately 13 hours of combined physician and staff time. Furthermore, 74% reported that prior authorization denials had increased over the preceding five years, while 94% indicated that prior authorization contributed to physician burnout.
These findings are significant not simply because of the number of administrative hours involved, but because of the opportunity cost associated with those hours. Time dedicated to satisfying payer requirements competes with patient care, clinical documentation, coordination with other providers, and operational responsibilities. The organizational consequences may include increased staffing needs, scheduling inefficiencies, reduced administrative capacity, and additional pressure on physician productivity.
The clinical implications also deserve executive attention. In the AMA survey, 95% of responding physicians reported that prior authorization delayed necessary care, and 79% reported that patients had abandoned treatment because of authorization challenges. These physician-reported experiences do not establish the frequency of such events across all patients or healthcare organizations. Nevertheless, they raise important concerns about how payer administrative processes may affect access to recommended services and continuity of treatment.
For physicians, these circumstances can create tension between clinical judgment and reimbursement requirements. A physician may recommend a treatment based on the patient’s medical condition, clinical history, and available evidence, only to encounter additional payer review before the patient can proceed. When approval is delayed or denied, the physician frequently remains responsible for explaining the situation, reconsidering treatment alternatives, or supporting an appeal. The resulting administrative burden can alter the physician-patient relationship by introducing financial and insurance considerations into decisions that patients may otherwise expect to be primarily clinical.
The consequences extend beyond individual encounters. Persistent administrative obstacles can influence organizational morale, physician satisfaction, and the ability to maintain efficient clinical operations. For healthcare executives managing physician groups, these challenges reinforce the need to evaluate payer administrative requirements as part of a broader strategy for workforce sustainability, patient access, and practice performance.
From Reactive Denial Management to Strategic Revenue Protection
Healthcare organizations have traditionally approached claim denials as problems to be resolved after claims are adjudicated. Under this model, revenue cycle personnel investigate rejected or denied claims, obtain missing information, submit corrections, and pursue appeals when appropriate. Although these activities remain necessary, a predominantly reactive approach can allow the same deficiencies to recur throughout the revenue life cycle, generating repeated administrative costs without addressing their underlying causes.
A more effective strategy begins with understanding where Denials originate and distinguishing between vulnerabilities within the provider’s control and reimbursement disputes requiring payer engagement. This framing helps prioritize improvement efforts and aligns internal controls with payer expectations. It sets a foundation for targeted training and process redesign.
Additionally, denials associated with incomplete registration, inaccurate insurance information, missing authorizations, coding inconsistencies, or insufficient documentation may indicate opportunities to improve internal processes. By mapping denial types to departments, teams can track outcomes and reduce delays. Tracking patterns over time reveals recurring issues needing policy updates.
Conversely, denials involving disputed medical necessity determinations, payer processing errors, or contractual reimbursement disagreements may require additional payer analysis, appeals management, or contract oversight.
This distinction is essential because aggregate denial rates can obscure materially different operational problems. Moreover, two physician practices reporting similar denial percentages may face very different financial exposure depending on their payer mix, service complexity, reimbursement methodologies, and the relative value of affected claims.
Likewise, a payer generating fewer denied claims may create greater financial disruption if those claims involve high-value procedures, lengthy appeal processes, or recurring reimbursement disputes.
Strategic denial management therefore requires a more sophisticated analytical framework.
Organizations should evaluate denial patterns by payer, reason, specialty, service line, financial value, and appeal outcome.
Moreover, time to resolution matters.
These measures can help leadership identify whether financial exposure concentrates in contracts, clinical workflows, operational departments, or administrative processes.
When connected to accounts receivable, cash flow, and reimbursement reporting, denial analytics can provide meaningful insight.
It reveals the financial consequences of recurring operational weaknesses.
Equally important is the relationship between denial management and revenue integrity. However, denial management addresses claims that have been rejected or disputed. Revenue integrity seeks to prove services are documented, captured, coded, billed, and reimbursed. A claim may be paid but not reimbursed under the applicable contract. A service may be delivered without being fully or accurately represented in billing. Therefore, effective financial oversight must consider payment accuracy and revenue leakage alongside denied claims.
This perspective creates an opportunity for physician organizations to connect clinical operations, payer contracting, coding, finance, and revenue cycle management.
Additionally, rather than expanding administrative resources solely to manage growing volumes of denials, leadership can use reimbursement intelligence.
Moreover, it identifies preventable problems, improves process accountability, and prioritizes interventions according to financial and operational impact.
A Changing Regulatory and Technological Environment
Recently, federal policy developments recognize the growing administrative burden of prior authorization. Moreover, CMS finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F) in January 2024. It establishes additional requirements for specified Medicare Advantage, Medicaid, Children’s Health Insurance Program, and federally facilitated marketplace payers.
As a result, the rule made certain operational requirements applicable in January 2026. These provisions aimed to improve prior authorization timelines and provide more specific reasons for denials. Additionally, they are scheduled for implementation beginning in 2027, with compliance dates varying by payer type. The rule primarily addresses prior authorization for covered medical items and services other than drugs. Its requirements should not be interpreted as applying uniformly to every commercial insurance arrangement.
These developments create opportunities for greater transparency and more efficient administrative workflows.
However, regulatory changes alone will not eliminate reimbursement complexity.
Physician practices must evaluate readiness to integrate electronic authorization capabilities.
They must also manage payer-specific requirements and use improved information to support operational decisions.
Moreover, treating regulatory compliance as isolated IT work may miss the chance to improve authorization governance and information quality.
Technology and artificial intelligence are also becoming increasingly prominent in discussions about denial prevention and revenue cycle performance. Additionally, automated eligibility verification, predictive claim editing, denial classification, and reimbursement analytics may help organizations identify errors earlier. They can also reduce manual effort. But benefits depend on data reliability, workflow design, and the organization’s ability to evaluate outcomes objectively.
For executives, technology investment should begin with a clearly defined financial or operational problem.
Avoid assuming that automation will independently resolve reimbursement challenges.
The relevant questions are whether a proposed solution improves claim accuracy.
Moreover, it reduces preventable denials, shortens reimbursement delays, and lowers administrative costs.
It provides greater visibility into payer performance.
Without defined measures of success and oversight, organizations risk extra technology expenses.
They may also leave the underlying causes of denials unresolved.
An Executive Imperative for Physician Organizations
Furthermore, the increasing burden of claim denials reflects a broader challenge in healthcare financial management.
Additionally, for physicians, that distance shows in outstanding claims and delayed payments, plus administrative hours.
Moreover, it also includes disrupted clinical workflows, reduced professional autonomy, and increased pressure on practice operations.
Healthcare executives should approach these issues as interconnected financial and operational risks rather than independent billing problems.
Effective oversight requires a comprehensive understanding of denial trends, payer performance, reimbursement accuracy, and administrative expense.
The clinical processes that influence financial outcomes also require attention across the organization.
Additionally, organizational accountability extends across patient access, physician leadership, coding, managed care, finance, and revenue cycle operations.
Moreover, payer requirements and reimbursement structures will continue to influence the operating environment.
Additionally, healthcare organizations retain opportunities to strengthen internal processes, improve financial visibility, and reduce preventable administrative work.
Furthermore, Denial management can enable better allocation of resources, stronger payer accountability, and a sustainable environment for physicians and patients.
Ultimately, the objective should extend beyond recovering denied reimbursement.
Moreover, healthcare organizations must develop the operational discipline and analytical capabilities needed to protect earned revenue.
This enables physicians to devote a greater proportion of their professional time to patient care.
How Assurance Healthcare Advisors Help
Assurance Healthcare Advisors works with physician practices, medical groups, and healthcare organizations to evaluate reimbursement performance, identify denial-related financial vulnerabilities, strengthen revenue integrity, and improve visibility into payer contract performance. By connecting financial analytics with operational assessment, AHA supports healthcare leadership in developing practical strategies to reduce avoidable revenue loss, improve reimbursement accountability, and strengthen organizational sustainability.
Organizations seeking a clearer understanding of denial performance and its financial implications are encouraged to connect with Assurance Healthcare Advisors to explore opportunities for targeted assessment and improvement.
Assurance Healthcare Advisors
Transforming healthcare challenges into strategic opportunities.